For help on how to get the results you want, see our search tips.
183 results
Categories
Human Remove Human filter
Medicine
Orphan designations Remove Orphan designations filter
Withdrawn applications Remove Withdrawn applications filter
Shortages Remove Shortages filter
Withdrawal type
Initial authorisation Remove Initial authorisation filter
-
List item
Withdrawn application: Rituximab Mabion (updated)
rituximab, date of withdrawal: 16/03/2020, Initial authorisation, Last updated: 24/06/2020 -
List item
Withdrawn application: Rituximab Mabion (updated)
rituximab, date of withdrawal: 16/03/2020, Initial authorisation, Last updated: 24/06/2020 -
List item
Withdrawn application: Fingolimod Mylan (updated)
fingolimod, date of withdrawal: 08/05/2020, Initial authorisation, Last updated: 17/06/2020 -
List item
Withdrawn application: Vynpenta (previously AvacopanChemoCentryx)
avacopan, date of withdrawal: 23/01/2019, Initial authorisation, Last updated: 15/05/2020 -
List item
Withdrawn application: Ekesivy
diclofenamide, date of withdrawal: 02/10/2019, Initial authorisation, Last updated: 06/03/2020 -
List item
Withdrawn application: Luxceptar
viable T-cells, date of withdrawal: 06/11/2019, Initial authorisation, Last updated: 17/02/2020 -
List item
Withdrawn application: Xyndari
glutamine, date of withdrawal: 18/09/2019, Initial authorisation, Last updated: 11/02/2020 -
List item
Withdrawn application: Idhifa
enasidenib, date of withdrawal: 06/12/2019, Initial authorisation, Last updated: 07/02/2020 -
List item
Withdrawn application: Nuzyra
omadacycline, date of withdrawal: 17/10/2019, Initial authorisation, Last updated: 05/02/2020 -
List item
Withdrawn application: Linhaliq
ciprofloxacin, date of withdrawal: 29/10/2019, Initial authorisation, Last updated: 24/01/2020 -
List item
Withdrawn application: Radicava
edaravone, date of withdrawal: 24/05/2019, Initial authorisation, Last updated: 14/08/2019 -
List item
Withdrawn application: Canakinumab Novartis
canakinumab, date of withdrawal: 04/12/2018, Initial authorisation, Last updated: 07/05/2019 -
List item
Withdrawn application: Efgratin
pegfilgrastim, date of withdrawal: 20/12/2018, Initial authorisation, Last updated: 05/04/2019 -
List item
Withdrawn application: Cavoley
pegfilgrastim, date of withdrawal: 20/12/2018, Initial authorisation, Last updated: 05/04/2019 -
List item
Withdrawn application: Graspa
asparaginase, date of withdrawal: 22/06/2018, Initial authorisation, Last updated: 23/01/2019 -
List item
Withdrawn application: Entolimod TMC
entolimod, date of withdrawal: 31/07/2018, Initial authorisation, Last updated: 12/12/2018 -
List item
Withdrawn application: Treprostinil SciPharm Sàrl
treprostinil, date of withdrawal: 05/09/2018, Initial authorisation, Last updated: 21/09/2018 -
List item
Withdrawn application: Restaysis
ciclosporin, date of withdrawal: 25/04/2018, Initial authorisation, Last updated: 06/08/2018 -
List item
Withdrawn application: Raligize
axalimogene filolisbac, date of withdrawal: 10/07/2018, Initial authorisation, Last updated: 27/07/2018 -
List item
Withdrawn application: Rotigotine Mylan
rotigotine, date of withdrawal: 22/12/2017, Initial authorisation, Last updated: 11/07/2018 -
List item
Withdrawn application: Prohippur
sodium benzoate, date of withdrawal: 03/04/2018, Initial authorisation, Last updated: 05/07/2018 -
List item
Withdrawn application: Fulphila
pegfilgrastim, date of withdrawal: 03/08/2017, Initial authorisation, Last updated: 29/05/2018 -
List item
Withdrawn application: Balimek
binimetinib, date of withdrawal: 04/01/2018, Initial authorisation, Last updated: 27/03/2018 -
List item
Withdrawn application: Infinia
alpha-1-antitrypsin, date of withdrawal: 21/06/2017, Initial authorisation, Last updated: 16/02/2018 -
List item
Withdrawn application: Zafiride
ngr-human tumour necrosis factor alpha, date of withdrawal: 01/06/2017, Initial authorisation, Last updated: 08/02/2018